FDAA

FDA approves label expansion of Alnylam’s Oxlumo for PH1
Pharmaceutical Business Review
Fri, 10/7/22 - 10:38 am
Alnylam
FDAA
Oxlumo
advanced primary hyperoxaluria
PH1